To assess the associations of semaglutide with incident CUD (first time diagnosis of CUD), the study population included 83,189 patients who had active medical encounters for the diagnosis of obesity in 6/202112/2022, were for the first time (new users design) prescribed semaglutide or non-GLP-1RA anti-obesity medications (bupropion, naltrexone, orlistat, topiramate, phentermine) [39] during 6/2021-12/2022 (time zero or index event), had no diagnosis of CUD on or before the index event and had a diagnosis of at least one of obesity-associated comorbidities (T2D, hypertension, hypercholesterolemia, hyperlipidemia, heart diseases, stroke) on or before the index event
If companies can sell these girls shame, if they can sell these girls body-dysmorphia, they can sell these girls the solution as medication and they can do so for life
Over time, they help establish sustainable habits that lead to consistent weight loss
Cell 185 , 6276 (2022)
Ligament Repair Evidence Ligaments connect bone to bone and provide joint stability
Researchers tracking missed-dose scenarios should reference the complete retatrutide guide for pharmacokinetic modeling considerations
